Trial
NCT03702920
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Instituto Grifols, S.A.
Collaborators
—
Condition
Acute-On-Chronic Liver Failure
Intervention
SMT + PE-A 5%
Why stopped
Due to corporate business reasons only (non-safety related decision)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04